About Laragen
Laragen is a Healthcare company based in Culver City (United States) founded in 1995, and was acquired by Transnetyx in August 2023. Genomic sequencing services are provided for academic and private sectors. Laragen offers products and services including Sanger Sequencing, Mouse Genotyping, MiSeq Sequencing, Cell Line ID, and Fragment Analysis. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Genomics. Its legal entity is Laragen, Inc. Its competitors include Omniome, Rejuvenate Bio and Genewiz; 2 of its 3 listed competitors have raised funding.
Company details
Laragen was founded in 1995 and is based in Culver City, United States. Genomic sequencing services are offered in the biotechnology sector, targeting both academic institutions and private companies. The portfolio encompasses Sanger sequencing, mouse genotyping, MiSeq sequencing, cell line identification, fragment analysis, microbial profiling, and identification services. Operations focus on reliable genetic analysis solutions across various applications.
- Headquarters Culver City, United States
- Stage Acquired
- SectorsHealthcare
- Website laragen.com
- Social LinkedIn
- Acquired by Transnetyx (Aug 2023)
- Legal Name Laragen, Inc
- Investors
- Acquired byTransnetyx
(Aug 2023)
Products & Services of Laragen
Laragen offers a comprehensive portfolio of products and services, including Sanger Sequencing, Mouse Genotyping, MiSeq Sequencing, Cell Line ID, and Fragment Analysis.
High-quality DNA sequencing for academic and company projects.
Accurate testing for transgenic and knock-out mice research.
Advanced sequencing for metagenomic and genomic studies.
STR-based testing for human cell line verification.
Reliable PCR fragment analysis for genetic applications.
rDNA-based identification of bacteria and fungi.
Investors in Laragen
Laragen has secured backing from 1 investor. Prominent investors backing the company include Transnetyx.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Automated genotyping services for murine cell lines are developed. | 2000 | transnetyx.com | Memphis, United States |
Investor details for Laragen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Laragen
1 people are tracked at Laragen (1 in leadership).
| Name | Role | Group |
|---|---|---|
jin Li | Owner | Leadership |
Complete people profiles for Laragen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Laragen
2 dated milestones of Laragen across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Laragen is founded.
- Exit Acquired by Transnetyx.
Competitors of Laragen
Laragen has 3 listed competitors in our database, 2 of them funded. They include Omniome, Rejuvenate Bio and Genewiz.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. |
Detailed competitors of Laragen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Laragen
Websites that share an audience with Laragen (laragen.com).
Websites whose visitors overlap most with Laragen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nucleics.com | 100% | 4.7K | #4,207,973 | View details | |
| genewiz.com | 100% | 218.6K | #157,582 | View details | |
| sequetech.com | 98% | 680.7K | View details | ||
acgtinc.com | acgtinc.com | 92% | #2,723,912 | – | |
| functionalbio.com | 85% | 2.7K | #5,720,004 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for Laragen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Laragen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Laragen
Complete news archive for Laragen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laragen
Laragen was founded in 1995.
Laragen is headquartered in Culver City, United States. It is registered at Culver City, California, United States.
Laragen was founded in 1995 and is based in Culver City, United States. Genomic sequencing services are offered in the biotechnology sector, targeting both academic institutions and private companies. The portfolio encompasses Sanger sequencing, mouse genotyping, MiSeq sequencing, cell line identification, fragment analysis, microbial profiling, and identification services. Operations focus on reliable genetic analysis solutions across various applications.
Laragen's top competitors include Omniome, Genewiz and Rejuvenate Bio.
Laragen offers Sanger Sequencing, Mouse Genotyping, MiSeq Sequencing, Cell Line ID, and 2 more products and services.
Laragen has 1 investor. Key investors include Transnetyx.
Laragen operates through Laragen, Inc.
Yes. Laragen was acquired by Transnetyx in August 2023.